1 ITEM 10.2 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT, dated as of the date of acceptance set forth below, is entered into by and between HARVARD SCIENTIFIC CORPORATION, a Nevada corporation, with headquarters located at 100...Registration Rights Agreement • April 21st, 1997 • Harvard Scientific Corp • Medicinal chemicals & botanical products • New York
2 MEMORANDUM OF AGREEMENTMemorandum of Agreement • June 25th, 1997 • Harvard Scientific Corp • Medicinal chemicals & botanical products
1 ITEM 10.1 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT, made and entered into this 19th day of April, 1996 by and between JACKIE R. SEE, M.D., hereinafter referred to as "CONSULTANT" and HARVARD SCIENTIFIC CORP., a Nevada corporation, hereinafter...Consulting Agreement • April 21st, 1997 • Harvard Scientific Corp • Medicinal chemicals & botanical products
1 ITEM 10.7 EXCHANGE AGREEMENT Exchange Agreement dated as of November 16, 1995, between Harvard Scientific Corp., a Nevada corporation with its principal address at 1601 East Flamingo, Suite 18, Las Vegas, Nevada 89119 ("Harvard") and Bio-Sphere...Exchange Agreement • April 21st, 1997 • Harvard Scientific Corp • Medicinal chemicals & botanical products
HARVARD SCIENTIFIC CORP. AND MR. MEDHAT GORGY PAGE 1 OF 6 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT, is made and entered into on the date signed below, by and between HARVARD SCIENTIFIC CORP., a Nevada corporation, with its World Headquarters...Consulting Agreement • July 20th, 1998 • Harvard Scientific Corp • Medicinal chemicals & botanical products • Nevada
HARVARD SCIENTIFIC CORP. FINANCING AGREEMENT FEBRUARY 23, 1998 Harvard Scientific Corp. ("Harvard") has requested that O. Lee Tawes III ("Investor") provide equity financing of $600,000. The Investor has agreed to do so on the following terms: BASIC...Financing Agreement • July 20th, 1998 • Harvard Scientific Corp • Medicinal chemicals & botanical products
EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT ("Agreement") is entered into as of this 14th day of November, 1997 by and between: HARVARD SCIENTIFIC CORP., NEVADA Corporation (hereinafter referred to as "HARVARD" OR THE "COMPANY"), having its...Employment Agreement • January 26th, 1998 • Harvard Scientific Corp • Medicinal chemicals & botanical products • Nevada
ARTICLE I GRANTHarvard Scientific Corp • April 21st, 1997 • Medicinal chemicals & botanical products
ADDENDUM TO CONSULTING AGREEMENT This is an Addendum to the Consultant Agreement dated April 19th , 1996, commencing April 1st, 1996, by and between HARVARD SCIENTIFIC CORP., NEVADA Corporation (hereinafter referred to as "HARVARD" OR THE "company"),...Consulting Agreement • January 26th, 1998 • Harvard Scientific Corp • Medicinal chemicals & botanical products
1 ITEM 10.3 LICENSING AGREEMENT This Agreement is entered into as of the 3rd November 1995, by and between Pharma Maehle, Ernst Grote Street 23,30196 Isernhagen, Germany, a privately held company organized under the laws of Germany (hereafter...Licensing Agreement • April 21st, 1997 • Harvard Scientific Corp • Medicinal chemicals & botanical products • Nevada
1 ITEM 10.9 CONSULTING AGREEMENT BETWEEN THE REGISTRANT AND I.W. MILLER & CO., INC. 2 FINANCIAL PUBLIC RELATIONS AGREEMENT This Financial Public Relations Agreement (this "Agreement") is made and entered into effective the 4th day of August, 1997,...Consulting Agreement • August 12th, 1997 • Harvard Scientific Corp • Medicinal chemicals & botanical products • Nevada
PREAMBLE:Consulting Agreement • April 21st, 1997 • Harvard Scientific Corp • Medicinal chemicals & botanical products • Florida
Harvard Scientific Corp. FINANCING AGREEMENT JANUARY 13, 1998 Harvard Scientific Corp. ("Harvard") has requested that Dr. Jackie R. See and Mr. Thomas E. Waite ("Investors") provide equity financing of up to $10,000,000 to be made in tranches...Financing Agreement • January 26th, 1998 • Harvard Scientific Corp • Medicinal chemicals & botanical products
Harvard Scientific Corp. ("Harvard") has requested that Dr. Jackie R. See and Mr. Thomas E. Waite ("Investors") provide equity financing of up to $10,000,000 to be made in tranches ("Tranches") of $500,000 to $2,000,000. The Investors have agreed to do so on the following terms:
PREMISESFinancial Public Relations Agreement • November 4th, 1997 • Harvard Scientific Corp • Medicinal chemicals & botanical products • Nevada
